Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
11.8M
-
Number of holders
-
98
-
Total 13F shares, excl. options
-
8.53M
-
Shares change
-
+2.62M
-
Total reported value, excl. options
-
$534M
-
Value change
-
+$183M
-
Put/Call ratio
-
0.32
-
Number of buys
-
66
-
Number of sells
-
-26
-
Price
-
$62.69
Significant Holders of PALVELLA THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PVLA) as of Q3 2025
107 filings reported holding PVLA - PALVELLA THERAPEUTICS, INC. - Common Stock, $0.001 par value per share as of Q3 2025.
PALVELLA THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PVLA) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.53M shares
of 11.8M outstanding shares and own 72.1% of the company stock.
Largest 10 shareholders include BVF INC/IL (1.16M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (822K shares), Frazier Life Sciences Management, L.P. (722K shares), First Light Asset Management, LLC (542K shares), VANGUARD GROUP INC (495K shares), BlackRock, Inc. (488K shares), PERCEPTIVE ADVISORS LLC (395K shares), Woodline Partners LP (346K shares), FEDERATED HERMES, INC. (339K shares), and Point72 Asset Management, L.P. (317K shares).
This table shows the top 98 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.